Biolator ApS: Financial statements 2023
CVR: 38609254
Biolator ApS (CVR 38609254) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -809,333 and a net result of DKK 143,139,188 compared with DKK -17,596 the year before. Equity amounted to DKK 137,108,672. The solvency ratio was 100%.
- Gross Profit
- -809,333 kr.
- Profit/Loss
- 143,139,188 kr.
- Equity
- 137,108,672 kr.
- Total Assets
- 137,147,188 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -809 t. | 143.1 mio. | 137.1 mio. | - |
| 2022 | - | -18 t. | -18 t. | 179 t. | - |
| 2021 | - | -6 t. | 3 mio. | 197 t. | - |
| 2020 | - | -17 t. | -17 t. | 17 t. | - |
| 2019 | - | - | 10 t. | 34 t. | 1 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Biolator ApS has published its annual report for 2022. Gross profit came to DKK -18,412, and the net result was DKK -17,596.
About Biolator ApS
Biolator ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Søren Kjærulff. The company is owned by Søren Kjærulff and Diana Bak. In 2025, the company reported a gross profit of DKK -1,051,063 and a net result of DKK -931,358 compared with DKK 6,166,939 the year before. Equity amounted to DKK 114,319,691.
